Menu

Experience

Amanda Fant

    • Cooley Advised Jazz Pharmaceuticals on Rule 144A Offering of $575 Million of Exchangeable Senior Notes 


    • Web.com to Buy Yodle for $342 Million 


    • Guardant Health Series D Financing 


    • Horizon Pharma to Acquire Hyperion Therapeutics for $1.1 Billion 


    • Horizon Pharma Acquires Hyperion Therapeutics for $1.1 Billion 


    • Horizon Pharma Completes $400 Million Exchangeable Senior Notes Offering 


    • Rovi Corporation Completes $345 Million Convertible Note Offering 


    • Horizon Pharma Acquires Vidara Therapeutics and Enters Five-Year $300 Million Term Loan Facility 


    • Jazz Pharmaceuticals plc Rule 144A Offering of $575 Million of Exchangeable Senior Notes 


    • Jazz Pharmaceuticals – $575 Million Exchangeable Senior Note Offering 


    • Horizon Pharma Acquires Vidara Therapeutics and Enters Five-Year $300 Million Term Loan Facility 


    • Jazz Pharmaceuticals $125 Million Acquisition of ADX-N05 


    • Brocade in $300 Million 4.625 % Senior Notes Offering 


Contact us

Back to top

© 2019 Cooley LLP and Cooley (UK) LLP. All rights reserved.

Cooley® is a registered service mark of Cooley LLP in the United States and European Union as well as certain other jurisdictions.